Analysts predict that Cavium, Inc. (NASDAQ:CAVM) will post $238.92 million in sales for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Cavium’s earnings. The lowest sales estimate is $238.18 million and the highest is $239.33 million. Cavium posted sales of $107.16 million in the same quarter last year, which indicates a positive year-over-year growth rate of 123%. The business is expected to report its next earnings results after the market closes on Wednesday, August 2nd.

On average, analysts expect that Cavium will report full-year sales of $238.92 million for the current fiscal year, with estimates ranging from $967.61 million to $978.66 million. For the next year, analysts forecast that the business will report sales of $1.10 billion per share, with estimates ranging from $1.07 billion to $1.13 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for Cavium.

Cavium (NASDAQ:CAVM) last released its earnings results on Wednesday, April 26th. The semiconductor provider reported $0.20 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.29 by $0.09. The company had revenue of $229.58 million for the quarter, compared to the consensus estimate of $227.22 million. Cavium had a negative net margin of 26.52% and a positive return on equity of 4.05%. The business’s revenue for the quarter was up 125.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.25 EPS.

Several equities research analysts recently commented on CAVM shares. Morgan Stanley increased their price target on Cavium from $75.00 to $80.00 and gave the company an “overweight” rating in a report on Friday, April 28th. MKM Partners reaffirmed a “buy” rating and issued a $81.00 price target (up previously from $77.00) on shares of Cavium in a report on Monday, May 1st. Needham & Company LLC reaffirmed a “buy” rating and issued a $78.00 price target (up previously from $77.00) on shares of Cavium in a report on Thursday, April 27th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $73.00 price target (up previously from $69.00) on shares of Cavium in a report on Thursday, April 27th. Finally, Macquarie started coverage on Cavium in a report on Thursday, March 30th. They issued an “outperform” rating and a $85.00 price target for the company. Seven analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $73.50.

TRADEMARK VIOLATION WARNING: This piece was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/07/19/238-92-million-in-sales-expected-for-cavium-inc-nasdaqcavm-this-quarter.html.

Cavium (NASDAQ CAVM) traded up 2.63% during trading on Wednesday, hitting $66.81. The stock had a trading volume of 966,015 shares. The company’s market cap is $4.54 billion. Cavium has a 12 month low of $41.57 and a 12 month high of $76.26. The company’s 50 day moving average is $66.99 and its 200-day moving average is $68.04.

In related news, VP Arthur D. Chadwick sold 40,000 shares of Cavium stock in a transaction on Tuesday, May 16th. The stock was sold at an average price of $75.14, for a total value of $3,005,600.00. Following the completion of the transaction, the vice president now directly owns 75,383 shares in the company, valued at $5,664,278.62. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Vincent P. Pangrazio sold 15,000 shares of Cavium stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $75.73, for a total value of $1,135,950.00. Following the completion of the transaction, the senior vice president now owns 60,039 shares of the company’s stock, valued at $4,546,753.47. The disclosure for this sale can be found here. Insiders own 4.65% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CAVM. IFP Advisors Inc raised its position in Cavium by 6.9% in the first quarter. IFP Advisors Inc now owns 1,559 shares of the semiconductor provider’s stock worth $112,000 after buying an additional 101 shares during the period. Solaris Asset Management LLC raised its position in Cavium by 52.4% in the first quarter. Solaris Asset Management LLC now owns 1,600 shares of the semiconductor provider’s stock worth $115,000 after buying an additional 550 shares during the period. US Bancorp DE raised its position in Cavium by 85.1% in the first quarter. US Bancorp DE now owns 1,888 shares of the semiconductor provider’s stock worth $135,000 after buying an additional 868 shares during the period. Bluestein R H & Co. bought a new position in Cavium during the first quarter worth about $215,000. Finally, FNY Partners Fund LP raised its position in Cavium by 1.2% in the first quarter. FNY Partners Fund LP now owns 3,400 shares of the semiconductor provider’s stock worth $243,000 after buying an additional 40 shares during the period.

Cavium Company Profile

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

Get a free copy of the Zacks research report on Cavium (CAVM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cavium Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc. and related companies with MarketBeat.com's FREE daily email newsletter.